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Cholesterol Accumulation in NPC1-Deficient
Neurons Is Ganglioside Dependent
did not impact brain cholesterol levels or the clinical
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Expression of individual types of gangliosides can
also be reduced genetically in NPC1/mice by crossingNiemann-Pick type C (NPC) disease is a lysosomal
disorder commonly caused by a recessive mutation these animals with mice in which specific genes for
GSL synthesis (e.g., GalNAcT) have been deleted. In ain NPC1, which encodes an integral membrane protein
with regions of homology to the morphogen receptor, previous study, such NPC1/ mice lacking GalNAcT
and thus GM2 and other complex gangliosides werePatched, and to 3-hydroxy-3-methylglutaryl coenzyme
A reductase [1, 2]. Neurons in NPC disease exhibit reported to exhibit no improvement in the clinical course
of disease, suggestive of a lack of significance of gangli-extensive storage of free cholesterol and glycosphin-
golipids (GSLs), including GM2 and GM3 gangliosides osides in NPC1 disease pathogenesis [13]. Given the
potential importance of these findings, we performed[3, 4, 5]. Most studies have viewed cholesterol storage
as primary, with NPC1 functioning as a retroendocytic a more extensive analysis of the relationship between
ganglioside and cholesterol storage in different braintransporter for regulation of cholesterol homeostasis
[3, 6, 7, 8]. Here, we analyze the effects of genetically regions of mice lacking both NPC1 and GalNAcT.
Brains from a total of 18 mice with the following geno-depriving NPC neurons of complex gangliosides by
creating mice doubly deficient in both NPC1 and the types, 5 NPC1//GalNAcT/, 3 NPC1//GalNAcT/,
5 NPC1//GalNAcT/, and 5 NPC1//GalNAcT/ atGSL synthetic enzyme, GM2/GD2 synthase (GalNAcT).
Ganglioside and cholesterol expression in neurons of 6 and 9 weeks of age, were analyzed for the presence
of unesterified cholesterol using filipin staining. In com-NPC1//GalNAcT/, NPC1//GalNAcT/, NPC1//
GalNAcT/, and WT mice was examined in situ by parison to control mice carrying wild-type GalNAcT and
NPC1, where unesterified cholesterol was not accumu-immunocytochemical and histochemical methods.
Neurons in double-deficient mice lacked intraneuronal lated, NPC1/ mice exhibited pronounced unesterified
cholesterol sequestration within neurons in all corticalGM2 accumulation as expected, but remarkably also
exhibited absence or dramatic reduction in free cho- areas, consistent with an earlier report [5]. Filipin stain-
ing was principally concentrated in abnormal axon hill-lesterol. Neurons storing cholesterol consistently
showed GM3 accumulation but some GM3-positive ock/perikaryal swellings (meganeurites) characteristic
of neuronal storage diseases [14]. Storage was particu-neurons lacked cholesterol storage. These findings
provide a compelling argument that cholesterol se- larly exacerbated in large layer V cortical pyramidal neu-
rons (Figure 1A, upper middle panel) and in neuronsquestration in NPC1-deficient neurons is ganglioside
dependent and suggest that the function of NPC1 in throughout the hippocampus, as exemplified by the
dentate gyrus and CA4 pyramids (lower middle panel).these cells may be more closely linked to homeostatic
control of GSLs than cholesterol. Introduction of the GalNAcT KO phenotype to NPC1-
deficient animals (Figure 1A, right panels) caused unes-
terified cholesterol accumulation to be markedly de-Results and Discussion
creased throughout the cerebral cortex, the hippocampus,
and other subcortical regions. Filipin staining in Gal-One approach to understanding the cellular mecha-
NAcT knockout mice with functional NPC1 resemblednisms underlying lipid storage in NPC disease, and
that observed in wild-type mice in that there was notherefore the function of NPC1, is through examination
accumulation of filipin-positive material within neuronalof the effects of pharmacologic or genetic reduction of
perikarya (not shown).specific classes of accumulating materials. Cholesterol-
Although substantial reduction in cholesterol accu-lowering drugs like lovastatin and cholestyramine in hu-
mulation was evident throughout the brain in double-mans [9] or probucol and nifedipine in mice [10] success-
deficient animals, careful analysis did reveal the pres-fully decreased circulating plasma cholesterol levels but
ence of cholesterol storage in subsets of neurons in
many brain regions including cerebral cortex. This result
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Figure 1. Cholesterol Expression Was Analyzed in the Cerebrum and Cerebellum of NPC1/ Mice Lacking Complex Gangliosides
Mice heterozygous for the NPC1 mutation and the GalNAcT deletion were crossed to generate double mutant NPC1/ mice unable to
synthesize higher order gangliosides.
(A) Filipin was used to stain for unesterified cholesterol (white) in cerebral cortex (top panel) and hippocampus (bottom panel). Cholesterol
was not accumulated in normal wild-type (WT) brains (left panel), but was stored throughout neurons of NPC-affected brains (middle) and to
a considerably lesser extent in double-deficient mouse brains (right panel).
(B) Analysis of unesterified cholesterol in cerebella of NPC1/ (middle panel) and double-deficient animals (bottom panel) showed no difference
in distribution as both exhibited numerous filipin-positive profiles throughout the cerebellar cortex, and particularly in the molecular layer.
Arrows illustrate Purkinje neurons that are still present and laden with unesterified cholesterol. As expected, WT mice (top panel) do not
abnormally sequester unesterified cholesterol within cell bodies. Bar  120 m for upper panels of (A) and 80 m for lower panels of (A); Bar
in (B)  200 m.
difference is that the portion of the cerebrum analyzed significantly elevated in NPC1-deficient neurons, as pre-
viously reported [5], and similar levels of GM3 stainingin the previous study may have represented a particular
subcortical region in which cholesterol accumulation were evident in double-deficient animals (Figure 2A). The
latter finding of no significant compensatory increase inwas absent or below detection.
In the cerebellum (Figure 1B), a severely affected brain GM3 storage in double-deficient mice versus NPC1/
animals is consistent with HPTLC analysis of this modelregion in NPC1 disease that exhibits extensive Purkinje
cell death and marked gliosis [5], the limitation of com- in earlier studies [13] and suggests that the accumula-
tion of GM2 and GM3 gangliosides in NPC1 disease mayplex ganglioside synthesis in double-deficient mice did
not significantly alter the degree of cerebellar degenera- be occurring by independent mechanisms. Comparison
of GM3 immunolabeling and filipin histochemical stain-tion. Staining with calbindin, a selective Purkinje cell
marker, at 9 weeks of age revealed that both NPC1/ ing in several brain regions of double-deficient mice
indicated that the unesterified cholesterol pattern paral-and double-deficient mice had few of these neurons
surviving (not shown). Filipin staining of cerebellum at leled that of GM3 ganglioside storage (Figures 2B–2D).
For example, cholesterol often accumulated in largethis age revealed the presence of numerous presump-
tive microglia/macrophages in the molecular layer of neurons of the deeper layers of the cerebral cortex and
in the CA3 region of hippocampus (right panels of Fig-both types of animals (Figure 1B, middle and lower pan-
els), with this being a characteristic index of the absence ures 2B and 2D, respectively), with this occurring in a
manner similar to GM3 storage in these same areasof Purkinje cells in a given area. Purkinje cells that were
present in both NPC1/ and double-deficient mice at (left panels of Figures 2B and 2D). In CA1 hippocampal
neurons where GM3 storage was absent, cholesterolthis age showed substantial perikaryal accumulation of
cholesterol (arrows). accumulation likewise did not occur (Figure 2C). Thus,
although unesterified cholesterol was dramatically de-By immunocytochemistry, GM3 ganglioside expres-
sion was not detected in normal brain but was found creased in most areas of brain in the double-deficient
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Figure 2. Regional Expression of GM3 Ganglioside and Unesterified Cholesterol Were Compared in Cerebral Cortex and Hippocampus
Analysis of the expression of the simple ganglioside, GM3, in NPC/ (A, left) and double-deficient mouse cerebral cortex (A, right) showed
no obvious compensatory increase in GM3 expression when GalNAcT was absent. The expression of GM3 ganglioside (brown) was assessed
in situ by immunocytochemistry and compared to unesterified cholesterol (white) determined by filipin staining in different brain regions. In
cortex (B) as well as in the CA1 (C) and CA3 (D) regions of the hippocampus, unesterified cholesterol expression (right panels) was proportional
to ganglioside expression (left panels). Notably, in CA1 neurons where little to no GM3 accumulation was found, cholesterol was also absent;
in CA3 neurons where GM3 was abundant, cholesterol accumulation was conspicuous. Bar  70 m for (A); 63 m for (B), (C), and (D).
animals, when it did occur, its accumulation consistently One brain region of double-deficient mice in which
cholesterol accumulation was not significantly dimin-followed that of GM3 ganglioside in those regions.
To determine whether the observed regional accumu- ished was the cerebellum (Figure 1B). When younger
double-deficient mice were analyzed at 5 and 6 weeks,lation of unesterified cholesterol was localized to the
same neurons that were accumulating GM3 ganglioside, the majority of Purkinje cells were intact and showed
punctate GM3 ganglioside colocalized to the same neu-double staining with GM3 antibody and filipin was per-
formed. Results showed that GM3 and unesterified cho- rons exhibiting filipin-positive vesicles (Figures 4A and
4B). In contrast, littermate mice recessive for the NPC1lesterol were commonly localized to the same neurons
within the cerebral cortex (Figure 3), a finding also ob- defect but normal for GalNAcT analyzed under the same
conditions, while positive for GM2 and cholesterol accu-served in the CA3 region of the hippocampus (not
shown). Occasionally, cholesterol storage was absent mulation, did not show detectable levels of GM3 storage
(Figure 4C). The presence of GM3 in Purkinje cell somatain neurons storing GM3 (Figure 3, inset A, arrowheads),
an indication that GM3 accumulation was not choles- of younger double-deficient animals and its association
with cholesterol storage indicates that in the absenceterol dependent. Interestingly, neurons lacking GM3
storage typically showed significant immunoreactivity of other gangliosides, altered expression of GM3 may
be elicited, at least in this cell type. This occurrence offor GD3, the other ganglioside made in the absence
of GalNAcT but not one reported to be pathologically GM3 and its colocalization with cholesterol is consistent
with findings from other brain regions and with the sug-elevated in NPC1 disease [5, 15]. The presence of cho-
lesterol storage in neurons containing GM3 but not in gestion that cholesterol accumulation in double-defi-
cient neurons is GM3 dependent. However, the degreethose with GD3 alone suggests not only linkage of the
cholesterol storage mechanism with GM3 accumulation of GM3 accumulation relative to cholesterol was less
than that typically observed elsewhere, e.g., in cerebralbut also that different types of neurons may have differ-
ent capacities and/or mechanisms for processing these cortical neurons where the two materials were equally
conspicuous (Figure 3).glycolipids. Normal neurons, which do not exhibit de-
tectable free cholesterol with filipin labeling [5], are also Average weight, longevity, and onset of clinical dis-
ease in NPC1/ and in double-deficient mice were alsoknown to express ample amounts of GD3 ganglioside
immunoreactivity in a punctate cytoplasmic pattern, investigated. In addition to the five double-deficient
mice described above, an additional six of these animalsconsistent with GD3 being a major ganglioside of neu-
rons in mammalian brain [16]. were produced and maintained for longevity studies.
Cholesterol and Gangliosides in NPC1 Disease
1327
Figure 3. Coexpression of Cholesterol and GM3 Ganglioside in Layer V Pyramidal Neurons of Double-Deficient Mouse Cerebral Cortex
Double labeling with an antibody to GM3 (red) and filipin histochemistry (blue) was performed on 15 m sections of double-deficient mouse
cerebral cortex and analyzed by fluorescence microscopy. Examples of neuronal nuclei are demarcated with an asterisk (*). Some neurons
exhibiting GM3 storage did not demonstrate cholesterol storage in the same plane (inset A, arrowheads), but cell profiles positive for filipin
and lacking GM3 were not observed. Cholesterol storage was localized to the same neurons as GM3 in meganeurites (arrows) and in associated
cell bodies of layer V pyramidal neurons (inset B). Bar  60 m for left panel; 20 m for insets A and B.
Similar to published assessments [13], we found that type earlier than littermate NPC1/ mice. Double-defi-
cient animals typically remained smaller than NPC1/the NPC1/ clinical phenotype was not consistently
improved by genetic depletion of complex gangliosides. mice throughout life and some developed ataxia, tremor,
and decreased mobility by approximately 5 weeks ofDouble-deficient animals exhibited clinical features typi-
cal of NPC1/ disease and some exhibited this pheno- age, whereas NPC1/ mice in our colony consistently
Figure 4. Cholesterol and GM3 Ganglioside
Coexpression Was Analyzed in Purkinje Neu-
rons of Double-Deficient Mice versus
NPC1/ Mice
Double labeling with antibody to GM3 (red)
and filipin (blue) was performed on 15 m
sections of cerebellum and analyzed by fluo-
rescence microscopy. Cholesterol storage
was abundant in Purkinje cells of 5-week-old
double-deficient (A, B inset) and in NPC1/
mice (C). Purkinje cells in double-deficient an-
imals also exhibited GM3 accumulation in as-
sociation with filipin-reactive regions of the
perikarya (B, arrows) whereas age-matched
NPC1/ Purkinje cells exhibited no GM3
immunoreactivity in conjunction with choles-
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